Ingeborg Hanbauer

Title: Ingeborg Hanbauer: Innovator in Ischemia Treatment

Introduction

Ingeborg Hanbauer is a notable inventor based in Chevy Chase, MD (US). She has made significant contributions to the field of medical science, particularly in the treatment of ischemia. Her innovative work focuses on the development of compounds that can protect tissues from damage caused by oxygen free radicals.

Latest Patents

Ingeborg holds 1 patent for her invention titled "Nitric oxide releasing compounds as protective agents in ischemia." This patent presents a method for treating oxygen free radical-induced tissue damage associated with ischemia reperfusion injury. The invention allows for the delivery of nitric oxide to target cells and tissues through the administration of a nitric oxide-containing compound that spontaneously releases nitric oxide under physiological conditions without requiring the presence of oxygen.

Career Highlights

Throughout her career, Ingeborg has worked with esteemed organizations, including the United States of America as represented by the Department of Health and Louisiana State University and Agricultural & Mechanical College. Her work has been instrumental in advancing the understanding and treatment of ischemic conditions.

Collaborations

Ingeborg has collaborated with notable individuals in her field, including David A Wink and James B Mitchell. These partnerships have contributed to the success and impact of her research.

Conclusion

Ingeborg Hanbauer's innovative contributions to ischemia treatment highlight her role as a leading inventor in the medical field. Her work continues to influence the development of protective agents against tissue damage, showcasing the importance of innovation in healthcare.